Nirsevimab and Hospitalization for RSV Bronchiolitis

Respiratory syncytial virus is a leading cause of bronchiolitis. In a prospective, multicenter, matched case–control study involving infants in France, nirsevimab decreased RSV-associated hospitalization by 83%.

​   The New England Journal of Medicine: Search Results in Pediatrics